Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.

Perotin JM, Leroy S, Marquette CH, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Barbe C, Deslee G; REVOLENS Study Group.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3645-3649. doi: 10.2147/COPD.S176366. eCollection 2018.

2.

Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.

Lejealle C, Paradis V, Bruno O, de Raucourt E, Francoz C, Soubrane O, Lebrec D, Bedossa P, Valla D, Mal H, Vilgrain V, Durand F, Rautou PE.

Chest. 2018 Oct 4. pii: S0012-3692(18)32500-5. doi: 10.1016/j.chest.2018.09.017. [Epub ahead of print]

PMID:
30292761
3.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Aug 23;52(2). pii: 1701898. doi: 10.1183/13993003.01898-2017. Print 2018 Aug.

PMID:
29976654
4.

Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I; REVOLENS study group.

Respir Res. 2018 May 9;19(1):84. doi: 10.1186/s12931-018-0796-x.

5.

Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient.

Brugière O, Cazes A, Champion L, Debray MP, Mourin G, Crestani B, Sroussi D, Bunel V, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Bouadma L, Mal H, Thabut G.

Transplantation. 2018 Jun;102(6):e255-e256. doi: 10.1097/TP.0000000000002153. No abstract available.

PMID:
29509571
6.

Morbidity and mortality related to pneumonia and TRACHEOBRONCHITIS in ICU after lung transplantation.

Tanaka S, Geneve C, Tebano G, Grall N, Piednoir P, Bronchard R, Godement M, Atchade E, Augustin P, Mal H, Castier Y, Montravers P, Desmard M.

BMC Pulm Med. 2018 Mar 5;18(1):43. doi: 10.1186/s12890-018-0605-9.

7.

Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.

Deslée G, Leroy S, Perotin JM, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dury S, Benzaquen J, Bonnaire M, Dukic S, Barbe C, Marquette CH; , on behalf of the REVOLENS Study Group13; REVOLENS Study Group.

Eur Respir J. 2017 Dec 21;50(6). pii: 1701740. doi: 10.1183/13993003.01740-2017. Print 2017 Dec. No abstract available.

PMID:
29269583
8.

Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis.

Menou A, Flajolet P, Duitman J, Justet A, Moog S, Jaillet M, Tabèze L, Solhonne B, Garnier M, Mal H, Mordant P, Castier Y, Cazes A, Sallenave JM, Mailleux AA, Crestani B.

FASEB J. 2018 Mar;32(3):1250-1264. doi: 10.1096/fj.201700583R. Epub 2018 Jan 3.

PMID:
29122847
9.

Smoking-Related Interstitial Fibrosis: Evidence of Radiologic Regression with Advancing Age and Smoking Cessation.

Fabre A, Treacy A, Lavelle LP, Narski M, Faheem N, Healy D, Dodd JD, Keane MP, Egan JJ, Jebrak G, Mal H, Butler MW.

COPD. 2017 Dec;14(6):603-609. doi: 10.1080/15412555.2017.1378631. Epub 2017 Oct 18.

PMID:
29043847
10.

Outcomes after lung transplantation.

Thabut G, Mal H.

J Thorac Dis. 2017 Aug;9(8):2684-2691. doi: 10.21037/jtd.2017.07.85. Review.

11.

Bronchiectasis Complicating Lung Volume Reduction Coil Treatment.

Debray MP, Marceau A, Dombret MC, Bunel V, Leroy S, Deslée G, Mal H.

Chest. 2017 Sep;152(3):e57-e60. doi: 10.1016/j.chest.2017.04.189.

PMID:
28889896
12.

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM).

Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, Broman G, Hillerdal G, Mal H, Pison C, Briault A, Downer N, Darwiche K, Rao J, Hübner RH, Ruwwe-Glosenkamp C, Trosini-Desert V, Eberhardt R, Herth FJ, Derom E, Malfait T, Shah PL, Garner JL, Ten Hacken NH, Fallouh H, Leroy S, Marquette CH; TRANSFORM Study Team *.

Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543. doi: 10.1164/rccm.201707-1327OC.

PMID:
28885054
13.

Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.

Koutsokera A, Royer PJ, Antonietti JP, Fritz A, Benden C, Aubert JD, Tissot A, Botturi K, Roux A, Reynaud-Gaubert ML, Kessler R, Dromer C, Mussot S, Mal H, Mornex JF, Guillemain R, Knoop C, Dahan M, Soccal PM, Claustre J, Sage E, Gomez C, Magnan A, Pison C, Nicod LP; SysCLAD Consortium.

Front Med (Lausanne). 2017 Jul 17;4:109. doi: 10.3389/fmed.2017.00109. eCollection 2017.

14.

FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice.

Justet A, Joannes A, Besnard V, Marchal-Sommé J, Jaillet M, Bonniaud P, Sallenave JM, Solhonne B, Castier Y, Mordant P, Mal H, Cazes A, Borie R, Mailleux AA, Crestani B.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L781-L795. doi: 10.1152/ajplung.00508.2016. Epub 2017 Jul 20.

15.

Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation.

Atchade E, Jean-Baptiste S, Houzé S, Chabut C, Massias L, Castier Y, Brugière O, Mal H, Montravers P.

Med Mycol Case Rep. 2017 May 18;17:4-7. doi: 10.1016/j.mmcr.2017.05.002. eCollection 2017 Sep.

16.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
17.

[Systemic corticosteroids during acute COPD exacerbations].

Mal H.

Rev Mal Respir. 2017 Apr;34(4):403-407. doi: 10.1016/j.rmr.2017.03.022. Epub 2017 Apr 25. French. No abstract available.

PMID:
28455140
18.

Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series.

Philippot Q, Cazes A, Borie R, Debray MP, Danel C, Hurtado Nedelec M, Boudjemaa S, Sroussi D, Dupin C, Mal H, Dauriat G, Jean-Baptiste S, Jebrak G, Castier Y, Mordant P, Thabut G, Brugière O.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601369. doi: 10.1183/13993003.01369-2016. Print 2017 Feb. No abstract available.

19.

Liver Involvement in Patients With PiZZ-Emphysema, Candidates for Lung Transplantation.

Morer L, Choudat L, Dauriat G, Durand F, Cazals-Hatem D, Thabut G, Brugière O, Castier Y, Mal H.

Am J Transplant. 2017 May;17(5):1389-1395. doi: 10.1111/ajt.14152. Epub 2017 Jan 24.

20.

Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.

Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B.

Eur Respir J. 2016 Dec;48(6):1721-1731. doi: 10.1183/13993003.02115-2015. Epub 2016 Nov 11.

21.

Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-β, IL-10 and HLA-G.

Dupin C, Lhuillier E, Létuvé S, Pretolani M, Thabut G, Mal H, Carosella E, Schilte C, Mordant P, Castier Y, Bunel V, Danel C, Rouas-Freiss N, Brugière O.

Transplantation. 2017 Sep;101(9):2192-2199. doi: 10.1097/TP.0000000000001553.

PMID:
27820781
22.

Functional connectivity and information flow of the respiratory neural network in chronic obstructive pulmonary disease.

Yu L, De Mazancourt M, Hess A, Ashadi FR, Klein I, Mal H, Courbage M, Mangin L.

Hum Brain Mapp. 2016 Aug;37(8):2736-54. doi: 10.1002/hbm.23205. Epub 2016 Apr 5.

23.

Airway-Centered Fibroelastosis: A Distinct Entity.

Pradere P, Gauvain C, Danel C, Debray MP, Borie R, Plantier L, Mal H, Aubier M, Crestani B, Taillé C.

Chest. 2016 Mar;149(3):767-74. doi: 10.1016/j.chest.2015.10.065. Epub 2016 Jan 8.

PMID:
26836939
24.

Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study.

Plantier L, Debray MP, Estellat C, Flamant M, Roy C, Bancal C, Borie R, Israël-Biet D, Mal H, Crestani B, Delclaux C.

J Breath Res. 2016 Feb 1;10(1):016005. doi: 10.1088/1752-7155/10/1/016005.

PMID:
26828240
25.

FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.

Joannes A, Brayer S, Besnard V, Marchal-Sommé J, Jaillet M, Mordant P, Mal H, Borie R, Crestani B, Mailleux AA.

Am J Physiol Lung Cell Mol Physiol. 2016 Apr 1;310(7):L615-29. doi: 10.1152/ajplung.00185.2015. Epub 2016 Jan 15.

26.

Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821.

PMID:
26757466
27.

Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.

Kannengiesser C, Borie R, Ménard C, Réocreux M, Nitschké P, Gazal S, Mal H, Taillé C, Cadranel J, Nunes H, Valeyre D, Cordier JF, Callebaut I, Boileau C, Cottin V, Grandchamp B, Revy P, Crestani B.

Eur Respir J. 2015 Aug;46(2):474-85. doi: 10.1183/09031936.00040115. Epub 2015 May 28.

28.

Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.

Borie R, Kannengiesser C, Hirschi S, Le Pavec J, Mal H, Bergot E, Jouneau S, Naccache JM, Revy P, Boutboul D, Peffault de la Tour R, Wemeau-Stervinou L, Philit F, Cordier JF, Thabut G, Crestani B, Cottin V; Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P).

J Heart Lung Transplant. 2015 Apr;34(4):538-46. doi: 10.1016/j.healun.2014.11.010. Epub 2014 Nov 13.

29.

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

Brugière O, Thabut G, Krawice-Radanne I, Rizzo R, Dauriat G, Danel C, Suberbielle C, Mal H, Stern M, Schilte C, Pretolani M, Carosella ED, Rouas-Freiss N.

Am J Transplant. 2015 Feb;15(2):461-71. doi: 10.1111/ajt.12977. Epub 2014 Dec 8.

30.

Post-operative kinetics of procalcitonin after lung transplantation.

Desmard M, Benbara A, Boudinet S, Mal H, Dehoux M, Thabut G, Montravers P.

J Heart Lung Transplant. 2015 Feb;34(2):189-94. doi: 10.1016/j.healun.2014.09.025. Epub 2014 Sep 28.

PMID:
25447581
31.

[Extracorporeal life support for patients with acute respiratory distress syndrome (adult and paediatric). Consensus conference organized by the French Intensive Care Society].

Richard C, Argaud L, Blet A, Boulain T, Contentin L, Dechartres A, Dejode JM, Donetti L, Fartoukh M, Fletcher D, Kuteifan K, Lasocki S, Liet JM, Lukaszewicz AC, Mal H, Maury E, Osman D, Outin H, Richard JC, Schneider F, Tamion F; French Intensive Care Society.

Rev Mal Respir. 2014 Oct;31(8):779-95. doi: 10.1016/j.rmr.2014.05.004. Epub 2014 Jun 25. French. No abstract available.

PMID:
25391514
32.

Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro.

Melboucy-Belkhir S, Pradère P, Tadbiri S, Habib S, Bacrot A, Brayer S, Mari B, Besnard V, Mailleux A, Guenther A, Castier Y, Mal H, Crestani B, Plantier L.

Am J Physiol Lung Cell Mol Physiol. 2014 Dec 1;307(11):L838-47. doi: 10.1152/ajplung.00012.2014. Epub 2014 Sep 26.

33.

Lung transplantation for advanced cystic lung disease due to nonamyloid kappa light chain deposits.

Hirschi S, Colombat M, Kessler R, Reynaud-Gaubert M, Stern M, Chenard MP, Métivier AC, Jeung MY, Mal H.

Ann Am Thorac Soc. 2014 Sep;11(7):1025-31. doi: 10.1513/AnnalsATS.201404-137OC.

PMID:
25118847
34.

Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference.

Richard C, Argaud L, Blet A, Boulain T, Contentin L, Dechartres A, Dejode JM, Donetti L, Fartoukh M, Fletcher D, Kuteifan K, Lasocki S, Liet JM, Lukaszewicz AC, Mal H, Maury E, Osman D, Outin H, Richard JC, Schneider F, Tamion F.

Ann Intensive Care. 2014 May 24;4:15. doi: 10.1186/2110-5820-4-15. eCollection 2014. Review.

35.

Histologic reconstruction of bronchiolar lesions in lung transplant patients with bronchiolitis obliterans syndrome.

Colombat M, Holifanjaniaina S, Hirschi S, Mal H, Stern M.

Am J Surg Pathol. 2014 Aug;38(8):1157-8. doi: 10.1097/PAS.0000000000000181. No abstract available.

PMID:
24698964
36.

Reply to the editor.

Gaudry S, Cohen Y, Rabbat A, Mal H.

J Thorac Cardiovasc Surg. 2014 Mar;147(3):1113-4. doi: 10.1016/j.jtcvs.2013.11.008. No abstract available.

37.

Impact of the humidification device on intubation rate during noninvasive ventilation with ICU ventilators: results of a multicenter randomized controlled trial.

Lellouche F, L'Her E, Abroug F, Deye N, Rodriguez PO, Rabbat A, Jaber S, Fartoukh M, Conti G, Cracco C, Richard JC, Ricard JD, Mal H, Mentec H, Loisel F, Lacherade JC, Taillé S, Brochard L.

Intensive Care Med. 2014 Feb;40(2):211-9. doi: 10.1007/s00134-013-3145-z. Epub 2013 Nov 26.

PMID:
24275900
38.

Neural mechanisms underlying breathing complexity.

Hess A, Yu L, Klein I, De Mazancourt M, Jebrak G, Mal H, Brugière O, Fournier M, Courbage M, Dauriat G, Schouman-Clayes E, Clerici C, Mangin L.

PLoS One. 2013 Oct 3;8(10):e75740. doi: 10.1371/journal.pone.0075740. eCollection 2013.

39.

Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia.

Gaudry S, Vincent F, Rabbat A, Nunes H, Crestani B, Naccache JM, Wolff M, Thabut G, Valeyre D, Cohen Y, Mal H.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):47-53. doi: 10.1016/j.jtcvs.2013.06.039. Epub 2013 Aug 19.

40.

Experience of extracorporeal membrane oxygenation as a bridge to lung transplantation in France.

Lafarge M, Mordant P, Thabut G, Brouchet L, Falcoz PE, Haloun A, Le Pimpec-Barthes F, Maury JM, Reynaud-Gaubert M, Saint-Raymond C, Sage E, Stern M, Thomas P, Castier Y, Dorent R, Mal H.

J Heart Lung Transplant. 2013 Sep;32(9):905-13. doi: 10.1016/j.healun.2013.06.009.

PMID:
23953818
41.

Mass spectrometry-based proteomic analysis: a good diagnostic tool for cystic lung light chain deposition disease.

Colombat M, Holifanjaniaina S, Guillonneau F, Mal H, Hirschi S, Reynaud-Gaubert M, Stern M.

Am J Respir Crit Care Med. 2013 Aug 1;188(3):404-5. doi: 10.1164/rccm.201301-0071LE. No abstract available.

PMID:
23905535
42.

Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation.

Thabut G, Christie JD, Mal H, Fournier M, Brugière O, Leseche G, Castier Y, Rizopoulos D.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1335-40. doi: 10.1164/rccm.201303-0429OC.

43.

Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.

Lê MP, Gervais A, Le Beller C, Long K, Larrouy L, Papy E, Mal H, Descamps D, Peytavin G.

J Antimicrob Chemother. 2013 May;68(5):1208-9. doi: 10.1093/jac/dks518. Epub 2013 Jan 20. No abstract available.

PMID:
23335198
44.

Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.

Brugière O, Suberbielle C, Thabut G, Lhuillier E, Dauriat G, Metivier AC, Gautreau C, Charron D, Mal H, Parquin F, Stern M.

Transplantation. 2013 Mar 15;95(5):761-5. doi: 10.1097/TP.0b013e31827afb0f.

PMID:
23296148
45.

[Cost-effectiveness of lung volume reduction coil treatment in emphysema. STIC REVOLENS].

Deslee G, Barbe C, Bourdin A, Durand-Zaleski I, Dutau H, Jolly D, Jounieaux V, Kessler R, Mal H, Pison C, Thiberville L, Vergnon JM, Marquette CH.

Rev Mal Respir. 2012 Nov;29(9):1157-64. doi: 10.1016/j.rmr.2012.09.010. Epub 2012 Oct 12. French.

PMID:
23200592
46.

The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.

Cigna N, Farrokhi Moshai E, Brayer S, Marchal-Somme J, Wémeau-Stervinou L, Fabre A, Mal H, Lesèche G, Dehoux M, Soler P, Crestani B, Mailleux AA.

Am J Pathol. 2012 Dec;181(6):2126-37. doi: 10.1016/j.ajpath.2012.08.019. Epub 2012 Sep 29.

PMID:
23031257
47.

Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient.

Stoclin A, Delbos F, Dauriat G, Brugière O, Boeri N, Métivier AC, Thabut G, Camus P, Mal H.

Vox Sang. 2013 Feb;104(2):175-8. doi: 10.1111/j.1423-0410.2012.01645.x. Epub 2012 Sep 18.

PMID:
22985417
48.

Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literature.

Lhuillier E, Brugière O, Veziris N, Danel C, Mourvilliers B, Mal H, Dauriat G, Ruimy R.

Exp Clin Transplant. 2012 Dec;10(6):618-20. doi: 10.6002/ect.2012.0052. Epub 2012 Jul 4. Review.

49.

One-year experience with high-emergency lung transplantation in France.

Boussaud V, Mal H, Trinquart L, Thabut G, Danner-Boucher I, Dromer C, Raymond CS, Reynaud-Gaubert M, Kessler R, Philit F, Dorent R, Stern M.

Transplantation. 2012 May 27;93(10):1058-63. doi: 10.1097/TP.0b013e31824d7079.

PMID:
22531492
50.

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients.

Cottin V, Harari S, Humbert M, Mal H, Dorfmüller P, Jaïs X, Reynaud-Gaubert M, Prevot G, Lazor R, Taillé C, Lacronique J, Zeghmar S, Simonneau G, Cordier JF; Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

Eur Respir J. 2012 Sep;40(3):630-40. Epub 2012 Feb 23.

Supplemental Content

Support Center